Spondyloenchondrodysplasia
Learn about Spondyloenchondrodysplasia, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: SPENCD; Spondyloenchondromatosis; Spondylometaphyseal dysplasia with enchondromatous changes
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
Spondyloenchondrodysplasia (SPENCD) is a very rare genetic skeletal dysplasia characterized clinically by skeletal anomalies (short stature, platyspondyly, short broad ilia) and enchondromas in the long bones or pelvis. SPENCD may have a heterogeneous clinical spectrum with neurological involvement (spasticity, intellectual disability and cerebral calcifications) or autoimmune manifestations, such as immune thrombocytopenic purpura, systemic lupus erythematosus hemolytic anemia and thyroiditis.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Antinuclear antibody positivity · Very frequent (99-80%)
- The presence of autoantibodies in the serum that react against nuclei or nuclear components.
- Metaphyseal dysplasia · Very frequent (99-80%)
- The presence of dysplastic regions in metaphyseal regions.
- Platyspondyly · Very frequent (99-80%)
- A flattened vertebral body shape with reduced distance between the vertebral endplates.
- Anti-dsDNA antibody positivity · Frequent (79-30%)
- The presence of autoantibodies (immunoglobulins) in the serum that react against double-stranded DNA.
- Autoimmunity · Frequent (79-30%)
- The occurrence of an immune reaction against the organism's own cells or tissues.
- Brain imaging abnormality · Frequent (79-30%)
- An anomaly of metabolism or structure of the brain identified by imaging.
- Chronic kidney disease · Frequent (79-30%)
- Functional anomaly of the kidney persisting for at least three months.
- Short stature · Frequent (79-30%)
- A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms).
- Spasticity · Frequent (79-30%)
- A motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with increased muscle tone, exaggerated (hyperexcitable) tendon reflexes.
- Abnormal periventricular white matter morphology · Occasional (29-5%)
- A structural abnormality of the myelinated axons (white matter) located near the cerebral ventricles.
- Abnormality of lateral ventricle · Occasional (29-5%)
- A morphological anomaly of the lateral ventricle.
- Abnormality of the nervous system · Occasional (29-5%)
- An abnormality of the nervous system.
- Arthritis · Occasional (29-5%)
- Inflammation of a joint.
- Autoimmune hemolytic anemia · Occasional (29-5%)
- An autoimmune form of hemolytic anemia.
Other findings in the same source
From: Orphanet
Additional reported features include Autoimmune thrombocytopenia (Occasional (29-5%)); Bowing of the legs (Occasional (29-5%)); Cerebral calcification (Occasional (29-5%)); Chorea (Occasional (29-5%)); Delayed eruption of teeth (Occasional (29-5%)); Dental malocclusion (Occasional (29-5%)); Disproportionate short-trunk short stature (Occasional (29-5%)); Enchondroma (Occasional (29-5%)); Global developmental delay (Occasional (29-5%)); Granuloma (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Childhood
Inheritance in the source
From: Orphanet
Autosomal recessive
Frequency and the population described
From: Orphanet
Reported case(s): 36.0; Worldwide. This is a published case count, not prevalence. Point prevalence: <1 / 1 000 000; Worldwide; Class only.
Understanding the inheritance label
From: MedlinePlus Genetics
An autosomal recessive pattern usually involves disease-causing changes in both copies of a gene. Parents may each carry one altered copy without having the condition themselves. A genetic counsellor can explain carrier testing and reproductive implications using the actual laboratory findings, rather than the condition name alone.
Which doctor should you see?
The suggested department for discussing Spondyloenchondrodysplasia is Orthopaedics, with a orthopaedic specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- What explains the change in pain, movement or function?
- Which activities need adjustment while the diagnosis is being clarified?
- What are the roles of rehabilitation, observation and surgery in this situation?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Spondyloenchondrodysplasia. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by an orthopaedic surgeon. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Spondyloenchondrodysplasia — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- MedlinePlus Genetics — inheritance patterns — Public-domain Genetics education
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-2217.